Literature DB >> 22083159

A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.

Cristian A Carvajal1, Carmen Campino, Alejandro Martinez-Aguayo, Juan E Tichauer, Rodrigo Bancalari, Carolina Valdivia, Pamela Trejo, Marlene Aglony, René Baudrand, Carlos F Lagos, Cecilia Mellado, Hernán Garcia, Carlos E Fardella.   

Abstract

Familial hyperaldosteronism type I is caused by an unequal crossover of 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes, giving rise to a chimeric CYP11B1/CYP11B2 gene (CG). We describe a family carrying a CG with high levels of free 18-hydroxycortisol but low prevalence of primary aldosteronism (PA) and an atypical CG inheritance pattern in a family of 4 generations with 16 adults and 13 children, we measured the arterial blood pressure, serum aldosterone, and plasma renin activity and then calculated the serum aldosterone:plasma renin activity ratio and urinary free 18-hydroxycortisol. We identified the CG by long-extension PCR and predicted its inheritance pattern. The CG was found in 24 of 29 subjects (10 children and 14 adults). In CG+ patients, hypertension and high 18-hydroxycortisol were prevalent (83% and 100%, respectively). High serum aldosterone:plasma renin activity ratio was more frequent in pediatric than adult patients (80% versus 36%; P<0.001). An inverse association between serum aldosterone:plasma renin activity ratio and age was observed (r=-0.48; P=0.018). Sequence analysis identified the CYP11B1/CYP11B2 crossover in a 50-bp region spanning intron 3 of CYP11B1 and exon 4 of CYP11B2. The CG segregation differs from an autosomal disease, showing 100% of CG penetrance in generations II and III. Statistical analysis suggests that inheritance pattern was not attributed to random segregation (P<0.001). In conclusion, we describe a family with an atypical CYP11B1/CYP11B2 gene inheritance pattern and variable phenotypic expression, where the majority of pediatric patients have primary aldosteronism. Most adults have normal aldosterone and renin levels, which could mask them as essential hypertensives.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083159     DOI: 10.1161/HYPERTENSIONAHA.111.180513

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Genetics of primary aldosteronism.

Authors:  Anand Vaidya; Amir H Hamrahian; Richard J Auchus
Journal:  Endocr Pract       Date:  2015-02-09       Impact factor: 3.443

Review 2.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

3.  Monogenic forms of low-renin hypertension: clinical and molecular insights.

Authors:  Priyanka Khandelwal; Jaap Deinum
Journal:  Pediatr Nephrol       Date:  2021-08-20       Impact factor: 3.651

Review 4.  Urinary Exosomes and Their Cargo: Potential Biomarkers for Mineralocorticoid Arterial Hypertension?

Authors:  Eric R Barros; Cristian A Carvajal
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-08       Impact factor: 5.555

Review 5.  The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor.

Authors:  Rene Baudrand; Anand Vaidya
Journal:  Int J Mol Sci       Date:  2018-02-11       Impact factor: 5.923

6.  GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.

Authors:  Yu-Ching Wu; Chia-I Chen; Peng-Ying Chen; Chun-Hung Kuo; Yi-Hsuan Hung; Kang-Yung Peng; Vin-Cent Wu; Jyy-Jih Tsai-Wu; Chia-Lang Hsu
Journal:  BMC Bioinformatics       Date:  2022-01-10       Impact factor: 3.169

7.  Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristóbal A Fuentes; Fidel Allende; Carmen Campino; Carolina Valdivia; Alejandra Tapia-Castillo; Tadashi Ogishima; Kuniaki Mukai; Gareth Owen; Sandra Solari; Cristian A Carvajal; Carlos E Fardella
Journal:  Reprod Biol Endocrinol       Date:  2013-08-13       Impact factor: 5.211

Review 8.  Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.

Authors:  Natalia Muñoz-Durango; Cristóbal A Fuentes; Andrés E Castillo; Luis Martín González-Gómez; Andrea Vecchiola; Carlos E Fardella; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2016-06-23       Impact factor: 5.923

Review 9.  Molecular Mechanisms of Primary Aldosteronism.

Authors:  Sergei G Tevosian; Shawna C Fox; Hans K Ghayee
Journal:  Endocrinol Metab (Seoul)       Date:  2019-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.